InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Hicks Derek, Dirigeant. Director active across 1 companies, notably Intellia Therapeutics, Inc.. In total, 2 reports have been recorded. The latest transaction was filed on 3 January 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
019,118 shares0
Common Stock
SEC:0001209191-22-001651·
019,118 shares0
Common Stock
SEC:0001209191-22-001651:0·
2 of 2 declarations
About Hicks Derek
Derek Hicks is the Executive Vice President and Chief Business Officer at Intellia Therapeutics, Inc. He oversees business operations and contributes to the company's development strategy. His role is essential in achieving growth objectives.
